Skip to Content


In the US, Rotigotine (rotigotine systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease and Restless Legs Syndrome.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of Parkinson's disease

Dopamine agonist

Chemical Names

(-)-(S)-5,6,7,8-tetrahydro-6-[propyl[2-(2-tienyl)etyl]amino]-1-naphtol (WHO)

(-)-(S)-6-[Propyl[2-(2-tienyl)etyl]amino]-5,6,7,8-tetrahydro-1-naphtol (IUPAC)

1-Naphtalenol, 5,6,7,8-tetrahydro-6-(propyl(2-(2-tienyl)etyl)amino)-, (S)-

Foreign Names

  • Rotigotinum (Latin)
  • Rotigotin (German)
  • Rotigotine (French)
  • Rotigotina (Spanish)

Generic Name

  • Rotigotine (OS: USAN, BAN, JAN)

Brand Names

  • Leganto
    Bayer Vital, Germany; UCB, Lithuania; UCB, Poland; UCB, Portugal
  • Neupro
    Abbott, Philippines; Abbott, Thailand; Bagó, Argentina; Biopas, Colombia; Laboratorios Andromaco, Chile; Medis Adria, Croatia (Hrvatska); Otsuka Pharmaceutical, Japan; Schwarz, Czech Republic; Schwarz, Lithuania; Schwarz, Romania; UCB, Australia; UCB, Canada; UCB, Finland; UCB, Greece; UCB, Hong Kong; UCB, Hungary; UCB, Ireland; UCB, Israel; UCB, Netherlands; UCB, Norway; UCB, Poland; UCB, Portugal; UCB, Singapore; UCB, Slovakia; UCB, United States; UCB Manufacturing, Denmark; UCB Nordic, Sweden; UCB Pharma, Austria; UCB Pharma, Belgium; UCB Pharma, Germany; UCB Pharma, Spain; UCB Pharma, France; UCB Pharma, United Kingdom; UCB Pharma, Italy; UCB Pharma, Slovenia; UCB-Pharma, Switzerland
  • Nubrenza
    UCB de Mexico, Mexico


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.